Vergleich

Biotinylated Human PD-1 / PDCD1 Protein, Avitag,His Tag (recommended for biopanning) Europäischer Partner

1.225,00 €
Zzgl. MwSt.
ArtNr PD1-H82E4-200ug
Hersteller ACROBiosystems
Menge 200ug
Kategorie
Typ Proteins Recombinant
Format Powder
Specific against Human (Homo sapiens)
Konjugat/Tag His; AVI
Purity >95% as determined by SDS-PAGE.
Citations (1) Ishida Y., et al., 1992, EMBO J. 11 (11): 3887-95. (2) Blank C., et al., 2007, Cancer Immunol. Immunother. 56 (5): 739-45. (3) Agata Y., et al., 1996, Int. Immunol. 8 (5): 765-72. (4) Freeman GJ., et al., 2000, J. Exp. Med. 192 (7): 1027-34. (5) Latchman Y., et al., 2001, Nat. Immunol. 2 (3): 261-8. (6) Yamazaki T., et al., 2002, J. Immunol. 169 (10): 5538-45.
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias PDCD1,PD1,CD279,SLEB2
Lieferbar
Buffer
PBS, pH7.4
Characteristics
This protein carries an Avi tag (Avitag) at the C-terminus, followed by a polyhistidine tag. The protein has a calculated MW of 18.6 kDa. The protein migrates as 35-45 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Description
Programmed cell death protein 1 (PD-1) is also known as CD279 and PDCD1, is a type I membrane protein and is a member of the extended CD28/CTLA-4 family of T cell regulators. PDCD1 is expressed on the surface of activated T cells, B cells, macrophages, myeloid cells and a subset of thymocytes. PD-1 has two ligands, PD-L1 and PD-L2, which are members of the B7 family. PD-L1 is expressed on almost all murine tumor cell lines, including PA1 myeloma, P815 mastocytoma, and B16 melanoma upon treatment with IFN-gamma. PD-L2 expression is more restricted and is expressed mainly by DCs and a few tumor lines. PD1 inhibits the T-cell proliferation and production of related cytokines including IL-1, IL-4, IL-10 and IFN-gamma by suppressing the activation and transduction of PI3K/AKT pathway. In addition, coligation of PD1 inhibits BCR-mediating signal by dephosphorylating key signal transducer. In vitro, treatment of anti-CD3 stimulated T cells with PD-L1-Ig results in reduced T cell proliferation and IFN-gamma secretion. Monoclonal antibodies targeting PD-1 that boost the immune system are being developed for the treatment of cancer.
Endotoxin Level
Less than 1.0 EU per ug by the LAL method.
Exp Region
Leu 25 - Gln 167
Expression System
HEK293
Molecular Weight
18.6 kDa
Molecule
PD-1
Shipping Conditions
RT
Storage
-20C

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 200ug
Lieferbar: In stock
Listenpreis: 1.225,00 €
Preis: 1.225,00 €
lieferbar

Lieferung vsl. bis 28.08.2025 

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen